John Robinson recruits a small band of Array vets to kickstart discovery at Cogent; Syntimmune co-founder takes charge at Arch Oncology

John Robinson

Biotech is a small world — and all the more so in a tight-knit community like Boulder, CO.

A serendipitous reunion with Andrew Robbins, a former colleague at Array, was what sparked John Robinson’s jump to his new gig as CSO of Cogent Biosciences.